文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

低氧血症严重程度与高频振荡通气在急性呼吸窘迫综合征中的疗效

Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01
一句话结论个体患者数据荟萃分析显示,高频振荡通气总体上不降低ARDS死亡率,但疗效随基线低氧血症严重程度而异,在非常严重低氧血症患者中可能降低死亡率。

该个体患者数据荟萃分析纳入4项随机试验共1552例成人ARDS患者,比较高频振荡通气(HFOV)与常规通气。基线平均PaO2/FiO2为114±39 mmHg,40%为重度ARDS(PaO2/FiO2<100 mmHg)。30天死亡率HFOV组40.9%(321/785) vs 对照组37.6%(288/767),校正OR 1.17(95%CI 0.94-1.46;P=0.16)。治疗效果随基线低氧血症严重程度变化(P=0.0003),轻中度ARDS患者随PaO2/FiO2升高伤害增加,非常严重ARDS患者可能死亡率降低。HFOV增加气压伤风险(校正OR 1.75;95%CI 1.04-2.96;P=0.04)。

要点

  • 在1552例成人ARDS患者中,HFOV组30天死亡率40.9%(321/785) vs 常规通气组37.6%(288/767),校正OR 1.17(95%CI 0.94-1.46;P=0.16),总体无显著差异。
  • 治疗效果随基线低氧血症严重程度变化(P=0.0003):轻中度ARDS患者随PaO2/FiO2升高,HFOV伤害增加。
  • 在非常严重低氧血症患者中,HFOV可能降低死亡率。
  • HFOV较常规通气增加气压伤风险(校正OR 1.75;95%CI 1.04-2.96;P=0.04)。
  • 肺顺应性和体重指数未改变HFOV的治疗效果。

适用人群与场景

  • 成人ARDS患者,来自4项比较HFOV与常规通气的随机试验,共1552例。
  • 基线平均PaO2/FiO2为114±39 mmHg;40%为重度ARDS(PaO2/FiO2<100 mmHg)。

研究设计与关键结果

  • 研究类型:个体患者数据荟萃分析,纳入4项随机试验共1552例成人ARDS患者。
  • 干预与对照:HFOV vs 常规通气。
  • 主要终点:30天死亡率HFOV组40.9%(321/785) vs 对照组37.6%(288/767),校正OR 1.17(95%CI 0.94-1.46;P=0.16)。
  • 治疗效果随基线低氧血症严重程度变化(P=0.0003):轻中度ARDS患者随PaO2/FiO2升高,HFOV伤害增加;非常严重ARDS患者可能死亡率降低。
  • 关键次要终点:HFOV增加气压伤风险,校正OR 1.75(95%CI 1.04-2.96;P=0.04)。
  • 肺顺应性和体重指数未改变治疗效果。

证据类型、等级与局限

  • 证据类型:个体患者数据荟萃分析(基于4项随机试验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于大多数ARDS患者,HFOV增加死亡率,不推荐常规使用。
  • 对于接受常规机械通气且存在严重低氧血症的ARDS患者,HFOV可能改善生存。
  • 使用HFOV时需警惕气压伤风险增加(校正OR 1.75;95%CI 1.04-2.96;P=0.04)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: High-frequency oscillatory ventilation (HFOV) is theoretically beneficial for lung protection, but the results of clinical trials are inconsistent, with study-level meta-analyses suggesting no significant effect on mortality.

OBJECTIVES: The aim of this individual patient data meta-analysis was to identify acute respiratory distress syndrome (ARDS) patient subgroups with differential outcomes from HFOV.

METHODS: After a comprehensive search for trials, two reviewers independently identified randomized trials comparing HFOV with conventional ventilation for adults with ARDS. Prespecified effect modifiers were tested using multivariable hierarchical logistic regression models, adjusting for important prognostic factors and clustering effects.

MEASUREMENTS AND MAIN RESULTS: Data from 1,552 patients in four trials were analyzed, applying uniform definitions for study variables and outcomes. Patients had a mean baseline PaO2/FiO2 of 114 ± 39 mm Hg; 40% had severe ARDS (PaO2/FiO2 <100 mm Hg). Mortality at 30 days was 321 of 785 (40.9%) for HFOV patients versus 288 of 767 (37.6%) for control subjects (adjusted odds ratio, 1.17; 95% confidence interval, 0.94-1.46; P = 0.16). This treatment effect varied, however, depending on baseline severity of hypoxemia (P = 0.0003), with harm increasing with PaO2/FiO2 among patients with mild-moderate ARDS, and the possibility of decreased mortality in patients with very severe ARDS. Compliance and body mass index did not modify the treatment effect. HFOV increased barotrauma risk compared with conventional ventilation (adjusted odds ratio, 1.75; 95% confidence interval, 1.04-2.96; P = 0.04).

CONCLUSIONS: HFOV increases mortality for most patients with ARDS but may improve survival among patients with severe hypoxemia on conventional mechanical ventilation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Meade MO, Young D, Hanna S, et al. Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2017. PMID: 28245137. doi:10.1164/rccm.201609-1938OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。